TY - JOUR
T1 - The Impact of Chronic Pulmonary Aspergillosis Co-infection on the Health-Related Quality of Life of Patients with Pulmonary Tuberculosis in Uganda
AU - Namusobya, Martha
AU - Bongomin, Felix
AU - Mukisa, John
AU - Batte, Charles
AU - Olwit, William Kane
AU - Rhein, Joshua
AU - Sekaggya-Wiltshire, Christine
AU - Prasad, Shailendra
N1 - Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Springer Nature B.V.
PY - 2023/10
Y1 - 2023/10
N2 - Background: Both pulmonary tuberculosis (PTB) and chronic pulmonary aspergillosis (CPA) significantly affect health-related quality of life (HR-QoL). We aimed to determine the impact of CPA co-infection on the HR-QoL of Ugandans with PTB. Methods: We conducted a prospective study as part of a larger study among participants with PTB with persistent pulmonary symptoms after 2 months of anti-TB treatment at Mulago Hospital, Kampala, Uganda between July 2020 and June 2021. HR-QoL was assessed using St. George Respiratory Questionnaire (SGRQ) at enrollment and at the end of PTB treatment (4 months apart). SGRQ scores range from 0 to 100, with higher score representing a poorer HR-QoL. Results: Of the 162 participants enrolled in the larger study, 32 (19.8%) had PTB + CPA and 130 (80.2%) had PTB. The baseline characteristics of the two groups were comparable. Regarding overall health, a higher proportion of the PTB group rated their HR-QoL as “very good” compared to those who had PTB + CPA (68 [54.0%] versus 8 [25.8%]). At enrollment, both groups had comparable median SGRQ scores. However, at follow up, the PTB group had statistically significantly better SGRQ scores (interquartile range); symptoms (0 [0–12.4] versus 14.4 [0–42.9], p < 0.001), activity ((0 [0–17.1] versus 12.2 [0–35.5], p =.03), impact (0 [0–4.0] versus 3.1 [0–22.5], p = 0.004), and total scores ((0 [0–8.5] versus 7.6[(0–27.4], p = 0.005). Conclusion: CPA co-infection impairs HR-QoL of people with PTB. Active screening and management of CPA in patients with PTB is recommended to improve HR-QoL of these individuals.
AB - Background: Both pulmonary tuberculosis (PTB) and chronic pulmonary aspergillosis (CPA) significantly affect health-related quality of life (HR-QoL). We aimed to determine the impact of CPA co-infection on the HR-QoL of Ugandans with PTB. Methods: We conducted a prospective study as part of a larger study among participants with PTB with persistent pulmonary symptoms after 2 months of anti-TB treatment at Mulago Hospital, Kampala, Uganda between July 2020 and June 2021. HR-QoL was assessed using St. George Respiratory Questionnaire (SGRQ) at enrollment and at the end of PTB treatment (4 months apart). SGRQ scores range from 0 to 100, with higher score representing a poorer HR-QoL. Results: Of the 162 participants enrolled in the larger study, 32 (19.8%) had PTB + CPA and 130 (80.2%) had PTB. The baseline characteristics of the two groups were comparable. Regarding overall health, a higher proportion of the PTB group rated their HR-QoL as “very good” compared to those who had PTB + CPA (68 [54.0%] versus 8 [25.8%]). At enrollment, both groups had comparable median SGRQ scores. However, at follow up, the PTB group had statistically significantly better SGRQ scores (interquartile range); symptoms (0 [0–12.4] versus 14.4 [0–42.9], p < 0.001), activity ((0 [0–17.1] versus 12.2 [0–35.5], p =.03), impact (0 [0–4.0] versus 3.1 [0–22.5], p = 0.004), and total scores ((0 [0–8.5] versus 7.6[(0–27.4], p = 0.005). Conclusion: CPA co-infection impairs HR-QoL of people with PTB. Active screening and management of CPA in patients with PTB is recommended to improve HR-QoL of these individuals.
KW - Chronic pulmonary aspergillosis
KW - Persistent symptoms
KW - Pulmonary tuberculosis
KW - Quality of life
KW - St. George Respiratory Questionnaire
KW - Uganda
UR - http://www.scopus.com/inward/record.url?scp=85159640020&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85159640020&partnerID=8YFLogxK
U2 - 10.1007/s11046-023-00741-1
DO - 10.1007/s11046-023-00741-1
M3 - Article
C2 - 37195546
AN - SCOPUS:85159640020
SN - 0301-486X
VL - 188
SP - 713
EP - 720
JO - Mycopathologia
JF - Mycopathologia
IS - 5
ER -